Related Experiment Video
Updated: Oct 7, 2025
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.9K
Insights for Quantifying the Long-Term Benefit of Immunotherapy Using Quantile Regression
Bassirou Mboup1,2, Christophe Le Tourneau1,3, Aurélien Latouche1,2
1Institut Curie, PSL Research University, INSERM, U900, Saint Cloud, France.
JCO Precision Oncology
|January 7, 2022
Summary
Immunotherapy offers survival benefits, but its delayed effect requires new metrics. Quantile regression effectively quantifies long-term immunotherapy response, showing a 60% survival advantage over chemotherapy.
Area of Science:
- Oncology
- Biostatistics
- Immunology
Background:
- Immunotherapy is approved for numerous tumor types, offering survival benefits.
- A key characteristic of immunotherapy is its delayed treatment effect due to late immune response.
- Traditional metrics like the hazard ratio are insufficient for quantifying long-term immunotherapy benefits.
Purpose of the Study:
- To propose and illustrate quantile regression for survival data as a method to quantify the long-term benefit of immunotherapy.
- To provide clinically understandable results without arbitrary time points or reliance on median survival.
- To offer a trial-specific approach for evaluating immunotherapy's sustained impact.
Main Methods:
- Utilized quantile regression for survival data to analyze long-term treatment effects.
- Employed reconstructed data from published Kaplan-Meier curves for method illustration.
- Avoided trial-specific metrics and arbitrary time point selections.
Main Results:
- Quantile regression demonstrated a quantifiable survival benefit for immunotherapy.
- Patients in the immunotherapy group had a 60% chance of surviving longer than those in the chemotherapy group.
- The estimated additional survival time was 5.46 months (95% CI, 2.57 to 9.02).
Conclusions:
- Quantile regression is a robust method for assessing the long-term survival benefits of immunotherapy.
- This approach provides clinically relevant insights into immunotherapy's efficacy beyond traditional metrics.
- The findings support the use of quantile regression for a more comprehensive evaluation of immunotherapeutic treatments.
Related Concept Videos
01:27Tumor Immunotherapy
719
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
719
01:21Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
191
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
191
01:20Comparing the Survival Analysis of Two or More Groups
335
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
335
01:24Kaplan-Meier Approach
296
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
296